Introduction
Host response to virus infection is characterized by the initial production of nonspecific inhibitors of virus replication including the type I interferons (IFNs) and other proinflammatory cytokines as part of the innate immune response. Thus, recognition of conserved molecular motifs on viral components, including both single-stranded RNA (ssRNA) and double-stranded RNA (dsRNA), by pattern recognition receptors, such as Toll-like receptors (TLR), or the cytosolic RNA helicases RIG-1 and Mda5 (Meylan et al., 2005) , results in the production of type I IFNs and other cytokines, that induce the production of specific proteins, that curtail the spread of virus by inducing an antiviral state in neighbouring cells. These cytokines also activate cellular immunity and the killing of virus-infected cells and play an important role in the establishment of the adaptive, antigen-specific immune response, culminating in the production of specific anti-viral antibodies and long-term protection to virus infection (Pestka et al., 1987; Biron et al., 1999) . It is becoming increasingly apparent, however, that other mechanisms and in particular virus-induced apoptosis play a determinant role in limiting certain virus infections (Lyles, 2000) . Although little is known about the molecular mechanisms underlying virus-induced apoptosis, both the type of virus and nature of the infected cell are thought to influence the specific pathways involved (Licata and Harty, 2003) . The role of p53 in virus-induced apoptosis remains controversial. Thus, the finding that vesicular stomatis virus (VSV) infection can activate the p53 protein (Takaoka et al., 2003) suggests that p53 may play a role in virus-induced apoptosis, whereas on the other hand, destabilization of the p53 reported during ssRNA virus infection suggests that p53 degradation may facilitate apoptosis induced by ssRNA viruses (Marques et al., 2005) . Both viral dsRNA and viral DNA have been shown, however, to induce apoptosis by mechanisms independent of both IFNs and p53 (Weaver et al., 2001) . The observation that certain virus-induced transcription factors such as interferon regulatory factor 1 (IRF-1) and IRF-3, which activate transcription of both IFN and IFN-induced genes (ISG), exhibit proapoptotic activity (Taniguchi et al., 2001; Weaver et al., 2001) suggests that virus-induced apoptosis and the IFN activation pathways may share common components. Thus, dsRNA, formed during the course of RNA or DNA virus replication, induces both IFN production and apoptosis (Castelli et al., 1997; Geiss et al., 2001) .
The initial events in host response to virus infection have been the subject of intense study. The interaction of viral dsRNA with TLR3 leads to the production of type 1 IFN by recruitment of the Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) adaptator (Yamamoto et al., 2002) and activation of TANK-binding kinase-1 (TBK1) and IkappaB kinase-e (IKK-e) kinases that phosphorylate IRF-3 and IRF-7 transcription factors (Fitzgerald et al., 2003; Bouker et al., 2004) . Recognition of dsRNA by the caspase recruitment domains of the cellular RNA helicases RIG-1 and Mda5, with homology to the caspase recruitment domain proteins (Yoneyama and Fujita, 2004) , also leads to phosphorylation of IRF-3. In both cases, phosphorylation of IRF-3 leads to protein homodimerization, translocation to the nucleus and association with co-activator molecules, such as CBP or p300 (Weaver et al., 1998) . This complex then binds to the IRF-E element, present within the promoters of type I IFN genes and some ISG genes, resulting in increased transcriptional activity.
The BH3-only proteins are essential initiators of programmed cell death as they bind to the antiapoptotic protein Bcl-2 or closely related proteins and launch the cell death program, which proceeds through the proapoptotic family members to the caspases. In mammals, at least four BH3-only genes, which include HRK, BIM, NOXA and PUMA, are subject to transcriptional control (Puthalakath and Strasser, 2002) . The NOXA and PUMA genes were initially described as transcriptional targets of p53 (Oda et al., 2000; Villunger et al., 2003) .
To determine the role of proapoptotic proteins in virus-induced apoptosis and the relationship between apoptosis and known signal-transduction pathways, we have analysed the expression of a number of different proapoptotic proteins before and after virus infection. Thus, sendai virus (SV) was shown to markedly activate NOXA through an interferon-independent pathway, and NOXA was shown, using RNA interference, to play an important role in virus-induced apoptosis. Furthermore, induction of NOXA by SV or VSV occurs through transcriptional activation by a p53-independent mechanism, involving post-translational modifications of the transcription factors IRF-1, IRF-3 and cAMPresponsive element binding protein (CREB).
Results

NOXA is induced during virus infection
To identify genes involved in the apoptotic pathway that may be regulated by viral infection, Bim, Bak, Bax, Bok, Puma, Noxa, Bid, Bik, Bad, Bcl-2 and Hrk transcripts were analysed by semi-quantitative reverse transcriptase (RT-PCR) using RNA from SV-infected MCF7 cells, which express a wild-type (wt) p53 gene. Analysis of mRNA levels at 2, 4, 8 and 18 h showed that the level of NOXA mRNA only was increased after virus infection (data not shown). These results were confirmed by Northern blot analysis (Figure 1a ). To determine whether Noxa mRNA induction was restricted to SV infection and/or dependent on p53 activation, experiments were carried out using HSV-1, a DNA virus and HuH7 cells, which contain a functionally inactive p53 gene (Moehler et al., 2001) . As shown in Figure 1a , both SV and HSV-1 infection markedly induced expression of NOXA transcripts in both p53 positive and negative cell lines.
To determine whether the induction of Noxa was dependent on IFN production, MCF7 cells were treated with recombinant IFN a2a or SV in the presence of a neutralizing polyclonal anti-IFN a/b antibody. Treatment of MCF7 cells with IFN a2a did not affect the expression of Noxa mRNA (Figure 1b) , whereas treatment of MCF7 cells with neutralizing anti-IFN a/b did not inhibit the ability of SV to induce the Together, these results strongly suggest that virus infection leads to the activation of a signal-transduction pathway responsible for the induction of Noxa, which is independent of either p53 or ISG activation.
NOXA mediates virus-induced apoptosis To determine whether induction of NOXA plays a role in virus-induced apoptosis, the effect of a specific decrease in NOXA expression, using interference RNA, was analysed in two viral model systems. HuH7 cells were infected with VSV and caspase-3 activity was measured and MCF7 cells were infected with SV and the apoptotic index was calculated. Expression of NOXA was efficiently blocked by Noxa-specific small interfering RNA (siRNA) when compared with scrambled siRNA (Figure 2a ). Both VSV-induced caspase activity in HuH7 cells and SV-induced apoptotis in MCF7 cells were markedly inhibited when the cells were transfected with Noxa-specific siRNA (Figure 2b, c) , strongly suggesting that NOXA plays a role in virus-induced apoptosis.
Virus-induced transcriptional activation of NOXA: identification of the transcriptional elements within the NOXA promoter that confer virus sensitivity To determine whether virus-induced expression of Noxa occurs through transcriptional activation of the NOXA gene, MCF-7 cells were transfected with the luciferase reporter gene under the control of a 1.2 kb DNA fragment of the region immediately upstream of the transcription initiation site of the NOXA gene. Infection of transiently transfected cells with SV resulted in a marked increase in luciferase activity, suggesting that SV is able to activate NOXA at the transcriptional level ( Figure 3) .
Sequence analysis of the 1.2 kb fragment of the NOXA promoter revealed the presence of putative IRF-E and CRE binding sites, for members of the IRF and CREB families, respectively, in addition to the p53 binding site identified previously (Oda et al., 2000) (Figure 3a) .
To determine the role of the IRF-E, CRE and p53 binding sites in virus-mediated induction of the NOXA gene, we constructed reporter plasmids containing the 1.2 kb region of the NOXA promoter mutated in the IRF-E, CRE and p53 binding sites or combinations of these mutations respectively. The transcriptional activity of these promoters was analysed following transient transfection of MCF7 cells, which expresses a wt p53 gene. Mutation of either the IRF-E or CRE binding sites resulted in an approximately threefold decrease in the level of induction of luciferase activity, following SV infection, compared to the wt promoter. Moreover, no increase in luciferase activity was observed following SV infection of MCF7 cells transfected with the double IRF-E/CRE mutant (Figure 3b ). These results suggest that viral induction of NOXA is dependent on the cooperative action of transcription factors binding to the IRF-E and CRE sites. Mutation of the p53 binding site did not affect the ability of SV to induce transcription of the NOXA gene, suggesting that p53 is not involved in SV responsiveness of the NOXA promoter. SV was also shown to increase the transcriptional activity of the NOXA promoter in HuH7 and HeLa cells, which are both defective in p53 activity (data not shown), again suggesting that p53 is not required for SV activation of the NOXA promoter.
To determine whether dsRNA, a replication intermediate of many ssRNA viruses, or other viruses Transcriptional activation of NOXA by ssRNA virus C Lallemand et al were able to activate the NOXA promoter, MCF7 cells transiently transfected with the reporter plasmids containing the wt or mutated NOXA promoter were treated with the dsRNA analog poly-dI-dC, or infected with VSV, measles virus (MV) or HSV-1 (Figure 3b ). VSV, MV and poly-dI-dC were found to activate the wt or mutated NOXA promoter reporter gene constructs in a manner similar to that observed with SV. In contrast, activation of the NOXA promoter by HSV was unaffected by mutations in either the IRF-E or CRE binding sites, suggesting that other unidentified binding sites are required for the induction of NOXA transcription by HSV, a DNA virus. Together, these data suggest that the NOXA promoter is inducible by both ssRNA viruses and by synthetic dsRNA and that induction involves activation of the IRF and CREB families of transcription factors.
Inactivation of the transcriptional activity of wt-p53 in response to either SV or VSV infection
To characterize the effect of RNA virus infection on p53-dependent transcriptional activity, MCF7 cells were transiently transfected with constructs encoding the luciferase gene under the control of either the wt or mutated p21 or NOXA p53-responsive elements (p53RE) cloned upstream to the SV40 minimum early promoter. Results were compared to those obtained with SV40 minimum early promoter (pGL2 vector from Promega, Madison, WI, USA). As a control, these reporter constructs were co-transfected with an expression vector encoding the p53 dominant-negative mutant, p53DD. In order to assess the specificity of the downregulation of the p53 transcriptional activity, we performed the same transfection using the entire SV40 early promoter (pGL2control, Promega) or the mutated p21 or NOXA p53RE cloned upstream to the SV40 minimum promoter. Experiments were also performed with a vector encoding the reporter gene under the control of the p21 or NOXA full-length promoter transfected either in p53-positive MCF7 or p53-negative H1299 cells. A schematic representation of the promoter constructs is given Figure 4a . The results were expressed relative to those obtained with cells transfected with the control expression vector, pcDNA3.1 (Figure 4b , c).
It is well known that the stress induced by transfection activates wt-p53 expression in various transformed cell lines and in particular in MCF-7, leading to a p53-dependent activation of the various promoters containing a p53 response element. In our experimental conditions, this is illustrated by the fact that the coexpression of p53DD leads to a decrease in the expression luciferase gene driven by either p21 or NOXA p53RE (Figure 4b ) or by p21 full-length promoter ( Figure 4c ) in MCF7 cells. Surprisingly, infection by either SV or VSV also strongly reduced the expression of every one of the reporter constructs having a functional p53RE upstream of the luciferase gene and this even to a greater extent than observed with p53DD ( Figure 4b ). These results strongly suggest that viral infection inactivates p53-mediated transcription. This assumption is further supported by the fact that (i) mutation within either p21 or NOXA p53RE abolished the downregulation of luciferase gene expression brought by either SV or VSV infection (Figure 4b ), (ii) viral infection had no effect on either the minimum or the full-length SV40 early promoter (Figure 4b) , and (iii) luciferase gene under the control of the p21 full-length promoter is not downregulated by viral infection in H1299, a p53-null cell line, in contrast to what is observed in MCF7 cells (Figure 3c ). We conclude therefore that infection has no side effect on the transcriptional activity of the reporter plasmids, but does inactivate the wt-p53 transcriptional activity per se.
Results presented in Figure 3 show that the induction of gene expression from the NOXA promoter in response to ssRNA viruses infection is independent of a functional p53RE. This conclusion is further supported by the results presented in Figure 4c showing that the expression of luciferase driven by full-length NOXA promoter is upregulated in response to viral infection in Identification of transcription factors involved in SV activation of the NOXA promoter To identify transcription factors involved in SV activation of the NOXA promoter, electrophoretic mobility shift assay (EMSAs) were carried out using oligonucleotide probes containing either wt or mutated forms of the IRF-E or CREB binding sites present within the NOXA promoter. Two complexes were identified using the IRF-E oligonucleotide and nuclear extracts of SV-infected MCF7 cells, which were not detected using nuclear extracts of uninfected cells (Figure 5a ). The specific unlabelled oligonucleotide efficiently competed for binding to these complexes, whereas the oligonucleotide containing a mutated IRF-E binding site did not. These results are in agreement with the results of transfection experiments, suggesting that the protein components of the retarded complexes may be involved in viral induction of the NOXA promoter. The slower and faster migrating complexes contain IRF-1 and IRF-3, respectively, as indicated by specific inhibition of complex formation following preincubation of the EMSA reaction mix with anti-IRF-1 or anti-phospho-IRF-3 (the activated form of IRF-3 present during virus infection as described previously (Lin et al., 1998) ), antibodies, respectively (Figure 5b ). Together, these results suggest that SV infection induces the binding of IRF-1 and phospho-IRF-3 at the IRF-E site of the NOXA promoter, leading to the transcription of NOXA.
An additional complex was identified using an oligonucleotide containing the CRE binding site that was specifically competed out by the unlabelled oligonucleotide. This complex was present in nuclear extracts from uninfected cells and the presence of which increased markedly following SV infection (Figure 5c ). The specific DNA-protein complex was super-shifted by an anti-CREB antibody, indicating the presence of CREB in this complex. Transcriptional activation of NOXA by ssRNA virus C Lallemand et al calcium-independent phospholipase A 2 (iPLA 2 ) pathway (Maggi et al., 2002) . To test whether iPLA2 pathway is also involved in CREB activation and NOXA induction by SV, MCF7 cells were pre-treated for 30 min with bromoenol lactone (BEL), which has been reported to inhibit iPLA 2 ,-induced phosphorylation (Williams and Ford, 2001; Maggi et al., 2002; Moran et al., 2005) . The effects of BEL treatment on CREB phosphorylation were analysed by Western blot and the effects of BEL on CREB activation were determined following transient transfection of MCF-7 cells with the NOXA promoter reporter gene constructs as described above. Pre-treatment of MCF7 cells with BEL decreased both phosphorylation of CREB ( Figure 6a ) and induction of both the wt and mutant IRF-E NOXA promoter constructs (Figure 6b ) following SV infection. In contrast, pretreatment of MCF7 cells with BEL did not affect induction of the mutant CRE following SV infection. Although these results do not rule out another pathway of CREB activation, they suggest that the phosphorylation of CREB via the iPLA2 pathway during infection may be involved in the NOXA induction. Moreover, BEL appears to act specifically on factors binding to the CRE site, as indicated by the observation that BEL did not affect virus induction of NOXA in cells transfected with the CRE mutant. Transcriptional activation of NOXA by ssRNA virus C Lallemand et al TLR3/TRIF pathway and has been reported previously to prevent the induction of IFN b by dsRNA (Yamamoto et al., 2002) . Although IRF-3 can also be phophorylated by the RGI-1 pathway (Meylan et al., 2005) , we have shown that nevertheless inactivation of the TLR3/TRIF in cells expressing delTRIF is sufficient to decrease significantly the phophorylation of IRF-3 following infection with SV, compared to virus-infected control cells (Figure 7a ).
In agreement with these results, induction of the NOXA promoter was also reduced in cells overexpressing the delTRIF mutant following infection with SV, compared to virus-infected control cells (Figure 7b ), whereas activation of the IRF-E mutant was unaffected. As expected, mutation of the CRE binding site decreased induction of the NOXA promoter by SV in delTRIF cells, compared to virus-infected control cells, while the CRE/IRF-E double mutant was unresponsive to virus induction in both delTRIF and control cells. Altogether, these results suggest that activation of the IRF-3 transcription factor by the TLR3/TRIF pathway is required for full induction of NOXA during SV infection.
Available data suggest that IRF-1 is regulated principally at the transcriptional level (Pine et al., 1990; Yokosawa, 2000, 2002) . To determine whether virus infection can activate IRF-1 through post-translational modification, MCF7 cells were co-transfected with the IRF-1 expression vector (Figure 8a ), suggesting that virus infection may be responsible for a post-translational modification of IRF-1. In an attempt to identify post-translational modifications of IRF-1 induced by virus infection, nuclear exacts from uninfected or SV-infected MCF7 cells were analysed by immuno-blotting with anti-IRF-1 antibodies after sodium dodecyl sulphate-polyacrylamide gel electrophoresis. As shown in Figure 8b , virus induction resulted in the appearance of forms of IRF-1 with a molecular weight of approximately 10 kDa greater than the constitutive form. Similar data were obtained using extracts from MCF7 cells transfected with a vector expressing IRF-1 tagged with His antigen tag (HAT) and revealed specifically using a His tag detection reagent (Figure 8c ). The total amount of IRF-1 was found to be significantly greater following viral infection (seeFigure 8b and c), suggesting that virus infection results in stabilization of IRF-1. To determine whether stabilization of IRF-1 requires protein neosynthesis, cells were treated with cycloheximide and infected with SV. This resulted in accumulation of the 36 kDa form of IRF-1 while accumulation of the 50 kDa form was inhibited (Figure 8d) . In an attempt to identify the peptide bound to IRF-1, immunoblots were treated successively with anti-sumo1, anti-ubiquitin or anti-ISG15 and anti-IRF-1 antibodies. No IRF-1 overlapping spots were observed in any of these experiments (data not shown).
Discussion
The cytolytic effect induced by a wide range of viruses contributes to the morbidity and mortality associated with virus infection. Although virus-induced cytolysis has all the hallmarks of apoptosis (Tanaka et al., 1998; Licata and Harty, 2003) , the mechanisms underlying this effect are poorly understood. The data presented in this report show that virus-induced apoptosis is accompanied by transcriptional upregulation of NOXA and that this event is independent of p53 activation but is dependent on the activation of IRF-1, IRF-3 and CREB. Virus-induced transcriptional activation of NOXA is accompanied by an increase in the Noxa protein and is functionally involved in the induction of apoptosis, as indicated by RNA interference analyses. During the preparation of this paper, a report appeared from another group implicating NOXA in apoptosis induced by IFN, dsRNA, encephalomyocarditis virus (EMCV) or VSV (Sun and Leaman, 2005) . Although the authors showed that regulation of NOXA by IFN and dsRNA was independent of p53, they did not analyse the effect of infection on p53 activation nor the transcription factors involved in this process.
Earlier reports suggested that virus-induced apoptosis was dependent on the action of IFNs (Tanaka et al., 1998) . Even though it remains to be determined how different viruses or other factors influence apoptosis, our results demonstrate that although activation of NOXA and induction of apoptosis by SV occur concomitantly with production of type I IFNs, both apoptosis and induction of NOXA are unaffected by the presence of neutralizing anti-IFN a/b antibody, strongly suggesting that SV-induced apoptosis is IFN independent. These findings are in agreement with those of Weaver et al.(2001) , who demonstrated that apoptosis induced by dsRNA or a paramyxovirus is independent of the action of interferon as it occurs in a variety of cells defective in their ability to produce IFN.
NOXA was first identified as a p53-regulated gene that may represent a mediator of p53-dependent apoptosis induced in response to genotoxic stress (Oda et al., 2000) . Our results show that NOXA can also be induced in a p53-independent manner since virus infection of a cell line containing a functionally inactive p53 also led to the overexpression of NOXA. Sequence analysis of the NOXA promoter revealed, in addition to the previously identified p53 binding site, the presence of CRE and IRF-E binding sites. The results of transient transfection experiments showed that both of these sites are required for NOXA induction by ssRNA viruses, while the p53 binding site does not appear to be involved in the induction of NOXA transcription following infection with either ssRNA or DNA viruses. This can be explained by ssRNA virus infection leading to the inactivation of the transcriptional activity of p53 as illustrated in transfection experiments showing that a reporter gene driven principally by a p53 response element is strongly repressed in virus-infected cells.
Although the NOXA promoter is highly inducible by HSV-1, a dsDNA virus, induction does not require either the IRF-E or the CRE binding sites. Studies are currently underway to identify the specific binding sites on the NOXA promoter that confer HSV-1 sensitivity.
A novel PKR-independent role for the iPLA 2 in viraland dsRNA-induced pathways has recently been identified (Maggi et al., 2002; Martinson et al., 2003) . iPLA 2 was shown to elicit phosphorylation of CREB and to stimulate the transactivation properties of this factor. Our results indicate that iPLA 2 is responsible for the phosphorylation of CREB induced by SV infection and that inactivation of iPLA 2 markedly inhibits virusinduced activation of the NOXA promoter. To our knowledge, this is the first report of the involvement of the iPLA 2 /CREB pathway in virus-induced apoptosis.
Virus-induced phosphorylation and activation through TLR3/TRIF or RGI-1 pathway of IRF-3 was identified as a key mechanism involved in the induction of type I IFNs (Yamamoto et al., 2004; Yoneyama and Fujita, 2004) . It has also been shown that expression of a constitutively active form of IRF-3 alone is sufficient to induce apoptosis and that a dominant-negative form of IRF-3 blocks SV-induced apoptosis (Heylbroeck et al., 2000) . Our data strongly suggest that the apoptotic activity of IRF-3 is most likely owing to its ability to transactivate the NOXA promoter.
We have shown that IRF-1 is able to bind to the IRF-E site and to transactivate the NOXA promoter during virus infection. We have also shown that overexpression of IRF-1 alone is insufficient to activate the NOXA promoter, and that induction of NOXA transcription also requires virus infection.
Although previous reports have suggested that IRF-1 is regulated principally at the transcriptional level (Nakagawa and Yokosawa, 2002) , our findings suggest that a post-translational modification of IRF-1 is required for the activation of the NOXA promoter. Thus, we have shown that the molecular weight of IRF-1 increases following SV infection. The nature of these modifications is currently under investigation. To date, several post-translational modifications of IRF-1 have been described, including phosphorylation, sumoylation and ubiquitination (Pine et al., 1990; Yokosawa, 2000, 2002) . Although ubiquitination/ sumoylation seem to be involved in regulating the halflife of IRF-1, the physiological role of this modification is still unclear. Post-translational modifications that regulate exclusively the stability of this protein cannot explain, however, the absence of transactivation of the NOXA promoter in the absence of viral infection in cells overexpressing IRF-1. In addition, although the 10 kDa increase in the molecular weight of IRF-1 observed in extracts of SV-infected cells is compatible with sumoylation or ISGylation, immunoblotting treated successively with anti-sumo or anti-ISG15 and anti-IRF-1 antibodies did not reveal any overlapping spots (data not shown), suggesting that an alternative form of protein modification occurs in this system.
The observation that the total amount of IRF-1 is significantly greater following viral infection suggests that one of the effects of virus infection is indeed on IRF-1 stabilization. Interestingly, in the presence of cycloheximide, the 36 kDa form of IRF-1 increases following SV infection, while accumulation of the 50 kDa form is inhibited. These results suggest that virus infection induces an initial modification of IRF-1, such as phosphorylation, that stabilizes the protein without affecting its molecular weight in the absence of protein neosynthesis, while in a second step that requires protein neosynthesis, virus infection results in covalent binding of an additional peptide to IRF-1 resulting in accumulation of the 50 kDa form of the protein.
We have shown that both IRF-1 and IRF-3 are able to transactivate NOXA by binding to the IRF-E site on the NOXA promoter. We have been unable to establish, however, which of these two factors prevails when they are both present, or, alternatively, whether they bind as a heterodimer. It has been shown previously that heterodimeric combinations of IRF-1 and IRF-3 mediate a stronger level of activation of the H4 promoter compared to that observed with the respective homodimers (Xie et al., 2001) . Thus, one could speculate that IRF-1 and IRF-3 may also bind to the NOXA promoter as a heterodimer following virus-induced post-translational modification of IRF-1.
It is well established that IRF-1 plays an important role in growth arrest due in part to the ability of IRF-1 to modulate the transcription of cytostastic genes such as P21 or P27(kip1) (Tanaka et al., 1996; Moro et al., 2000) or proapoptotic genes such as CASPASE-7, -8 and -1 and FAS ligand (Chow et al., 2000; Sanceau et al., 2000; Ruiz-Ruiz et al., 2004) . The results of the present study show that NOXA should be added to the list of the proapoptotic genes upregulated during growth arrest and attest to the central role played by IRF-1 in the induction of apoptotis.
The observation that inhibition of the phosphorylation of CREB does not affect IRF-1/IRF-3 activation of the NOXA promoter and that inhibition of phosphorylation of IRF-3 through the TLR3/TRIF pathway does not affect the ability of CREB or IRF-1 to activate the NOXA promoter suggests that virus-induced activation of IRF-1, IRF-3 and CREB occurs through independent signaling pathways illustrating the stringent control that underlies virus-induced cellular apoptosis.
Materials and methods
Cell lines and culture
The MCF-7, HuH7 and H1299 cells lines were maintained at 371C, in 5% CO 2 /air in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin. The delTRIF MCF7 population was established by stable transfection of MCF7 cells using the pIRESdelTRIF-Hygro bicistronic vector followed by 4 weeks of culture in medium containing 200 mg/ml of hygromycin.
Antibodies
The antibodies used to detected IRF-1 (c-20), IRF-3 (sc-9082), CREB (sc 186) and phospho-CREB (sc 7978) were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The IRF-1-HAT fusion protein was detected using the universal HIS Western blot kit (Clontech, Mountain View, CA, USA). The antiphospho IRF-3 antibody was from Upstate (Charlottesville, VI, USA). The anti-Noxa (ab-1) antibody was from Oncogene Research Products (San Diego, CA, USA). The monoclonal antibody DO-7, directed against p53, was a gift from Dr D Lane.
Plasmid construction The 1.2 kb human NOXA promoter was obtained by PCR using human genomic DNA as a template and the following oligonucleotide primers: forward (5 0 -gacctcgagcagggcagtgct ctctgcc-3 0 ) and reverse (5 0 -gacaagcttcccaggcatctccg-3 0 ), and inserted at the XhoI/Hind III sites of the pGL3basic (Promega). The mutant constructs mtIRF-E, mtCRE and mtp53 were created by PCR-based mutagenesis by substituting in the wt promoter the sequences described in the Figure 3a . The double-mutant mtIRF-E/CRE was obtained using the same procedure with the mtIRF-E oligonucleotide pair and the mtCRE promoter as a template. The cDNA of delTRIF was obtained by one-step RT-PCR (AccessQuick RT-PCR system, Promega) using RNA from MCF7 cell and the following oligonucleotides forward (5 0 -gtcatggccctgttcccttcct ccctgg-3 0 ) and reverse (5 0 -ttacctccacatggcctttcgggcc-3 0 ). This cDNA was blunt-end cloned in the biscitronic vector pIREShygro (Clontech), digested and filled at EcoRI site. This construct was called pIRESdelTRIF-Hygro. The IRF-1 and IRF-1-HAT expression vectors were constructed by TA cloning the cDNA of IRF-1 or IRF-1 HAT in the pCDNA3.1 (Invitrogen). The cDNA of IRF-1 was obtained by one-step RT-PCR (AccessQuick RT-PCR system, Promega) using RNA from MCF7 cells and the following oligonucleotides: forward (5 0 -aacatgcccatcactcggatgc-3 0 ) and reverse (5 0 -ctac ggtgcacagggaatggc-3 0 ). The cDNA of IRF-1-HAT was obtained using the same procedure, except that the reverse primer contained the HAT coding polypeptide as a fusion protein.
The NOXAp53RE and the NOXAp53REm were obtained by cloning the wt and mutated p53-responsive sequence described in Figure 4a at the XhoI/BglII sites upstream of the SV40 promoter sequence of pGL2-control vector (Promega). The pDDm-TO vector was described previously (Miro-Mur et al., 2003) . It encodes the mouse p53DD truncated protein, a p53 dominant-negative mutant. The p21p53RE and the p21p53REm were described previously (Munsch et al., 2000) . The 2.1 kb human p21 promoter was obtained by PCR using human genomic DNA as a template and the following oligonucleotide primers: forward (5 0 -gtctcgagccatccctatgct gcctgct-3 0 ) and reverse 5 0 -ctaagcttcctctgagtgcctcggtgcc-3 0 , and inserted at the XhoI/HindIII sites of the pGL3basic (Promega).
Transfections
Transient transfections of MCF7 cells were performed in a 48-well plate using 0.5 mg of reporter construct, 0.01 mg of normalization vector pRLSV40 (Promega) and 1 ml of superfect reagent (Qiagen, Hilden, Germany). Infection with various viruses at a multiplicity of infection (MOI) was performed 1 or 18 h after transfection as indicated in the legends. Values for firefly luciferase were normalized to the corresponding Renilla luciferase values to obtain relative luciferase units (RLU). The data presented here were obtained from at least three independent transfection experiments, the s.d., not shown in the figures in the interests of clarity was in each case less than 15%.
Assay for cell survival and apoptosis HuH7 and MCF7 cells were transfected in a 96-well plate with 10 nM of RNA interference (RNAi) direct against Noxa (5 0 -aacugaacuuccggcagaaactt-3 0 ) or the scrambled RNAi (5 0 -aauc gcacagaucagacucagtt-3 0 ) using 2 ml of TransIT-TKO (Mirus, Madison, WI, USA). After 4 h of incubation, HuH7 and MCF7 cells were infected with VSV at an MOI of 1.0 during 18 h, or with SV at an MOI of 10, respectively, for 48 h.
Caspase-3 activity in HuH7 was determined using the Caspase glow 3/7 assay (Promega). The apoptotic index of MCF7 cells was determined by staining the cells with MitoSensor (Becton Dickinson, San Jose, CA, USA) and analysed by flow cytometry.
Northern blot analysis RNA was isolated from cells at various times after infection, as indicated in the legend, using QIAquick system (Qiagen). Twenty micrograms of RNA were separated on a agarose gel, transferred to Hybond N membrane (Amersham Biosciences, New Jersey, USA) and probed with radiolabelled human Noxa, Puma, Bim, generated by RT-PCR (AccessQuick RT-PCR system, Promega) using mRNA from human PBMC and the following primers: Noxa forward (5 0 -tgggaagaaggcgcgcaa ga-3 0 ) and reverse (5 0 -cagaagtttctgccggaagt-3 0 ), Puma forward (5 0 -agctccccggagcccgtaga-3 0 ) and reverse (5 0 -ttgtctccgccgctcgt act-3 0 ), Bim forward (5 0 -ggcaaagcaaccttctgatg-3 0 ) and reverse (5 0 -tgtctgtagggaggtagggg-3 0 ).
Electrophoretic mobility shift assay Nuclear extracts were prepared using a modification of the procedure described by Osborn et al.(1989) . Nuclear proteins were extracted from uninfected cells and from cells infected 8 h with SV at an MOI of 1.0. The double-stranded oligonucleotides used include putative IRF-E of NOXA promoter 5 0 -gatctcgaaaagtttccttttccaatctctttt ct-3 0 , the mutated version of this probe, mtIRF-E 5 0 -gatctcga aacgaattcggatccaatctcttttct-3 0 , the putative CRE binding site of NOXA promoter 5 0 -acgtctagtttccctacgtcaccagggaagttct-3 0 , and mutant mtCRE NOXA oligonucleotide 5 0 -acgtctagtttccctaatc caccagggaagttct-3 0 . For supershift analysis, 1 mg of antibody against IRF-1, phopho-IRF-3 and CREB was added to the reaction mixture for 20 min at 41C before the addition of the labelled oligonucleotides.
